Iguana Healthcare Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-50,000
Closed -$1.24M 64
2017
Q4
$1.24M Sell
50,000
-75,000
-60% -$2.07M 0.81% 43
2017
Q3
$3.65M Buy
125,000
+70,000
+127% +$1.93M 1.99% 18
2017
Q2
$1.52M Buy
+55,000
New +$1.46M 0.86% 41
2017
Q1
Sell
-65,000
Closed -$1.41M 73
2016
Q4
$1.41M Sell
65,000
-35,000
-35% -$764K 0.84% 37
2016
Q3
$2.38M Hold
100,000
0.42% 63
2016
Q2
$2.34M Sell
100,000
-100,000
-50% -$2.16M 0.95% 34
2016
Q1
$3.76M Buy
+200,000
New +$3.51M 1.38% 25

Other funds holding BSX

Iguana Healthcare Management's BSX Position: Q1 2018 in Review

Iguana Healthcare Management sold out of Boston Scientific (BSX) in Q1 2018, closing a stake of 50,000 shares — an estimated $1.24M sold.

Iguana Healthcare Management first reported a position in BSX in Q1 2016 and held it in 7 quarters. The position peaked at $3.76M in Q1 2016. 633 funds tracked by Wall St. Rank hold BSX as of Q1 2018.

  • Iguana Healthcare Management reported no remaining Boston Scientific position as of Q1 2018 after selling out during the quarter.
  • Iguana Healthcare Management sold 50,000 Boston Scientific shares in Q1 2018, an estimated $1.24M.
  • Iguana Healthcare Management first reported a position in Boston Scientific in Q1 2016 and held it in 7 quarters.
  • Iguana Healthcare Management's Boston Scientific position peaked at $3.76M in Q1 2016.
  • 633 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2018.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.